Cargando…

OR18-03 Peripheral But Not Hepatic Insulin Resistance Associates With Adverse Vascular And Metabolic Health In Type 1 Diabetes: A Possible Target For Adjunctive Therapy

Disclosure: J.R. Snaith: None. N. Olsen: None. G. Kowalski: None. C. Bruce: None. J. Holmes-Walker: None. J.R. Greenfield: None. Insulin resistance in type 1 diabetes (T1D) is a cardiometabolic risk factor that is potentially targetable with adjunctive therapy. Prior studies of metformin in T1D have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Snaith, Jennifer R, Olsen, Nicholas, Kowalski, Greg, Bruce, Clinton, Holmes-Walker, Jane, Greenfield, Jerry R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Diabetes And Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557016/ http://dx.doi.org/10.1210/jendso/bvad114.895

Ejemplares similares

MON-LB113 Insulin Resistance in Type 1 Diabetes Managed With Metformin (INTIMET): Rationale and Study Design of a Randomised Placebo-Controlled Trial
por: Snaith, Jennifer R, et al.
Publicado: (2020)

OR03-3 Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes
por: Khan, Shanzay, et al.
Publicado: (2022)

OR03-4 Efficacy and Safety of Avexitide for Treatment of Hypoglycemia after Gastrointestinal Surgery; Assessment of Novel Dosing Regimens in an Expanded Indication
por: Craig, Colleen, et al.
Publicado: (2022)

OR12-03 The Pancreatic Islet Alpha Cell Arginine Transporter SLC7A2 Regulates Arginine-induced Glucagon Secretion and Glycemia
por: Stanley, Jade E, et al.
Publicado: (2023)

OR03-5 Identification of Four New Glucotypes during the First Year after Type 1 Diabetes Onset Using Continuous Glucose Monitoring Metrics
por: Delfosse, Antoine, et al.
Publicado: (2022)

THU298 Effect Of SGLT2 Inhibition On Metabolic, Cardiac And Renal Outcomes In Heart Transplant Recipients (EMPA-HTx study): Protocol And Study Design
por: Raven, Lisa M, et al.
Publicado: (2023)

OR34-03 Defining Clinical Characteristics Of Patients With Severe Hypoglycemia After Roux-en-Y Gastric Bypass: How Do They Differ From Asymptomatic Patients?
por: Grover, Ashna, et al.
Publicado: (2023)

OR03-1 Achievement of HbA1c <6.5% without weight gain and hypoglycemia in people with type 2 diabetes treated with tirzepatide across the phase 3 SURPASS program
por: Allen, Sheryl Elaine, et al.
Publicado: (2022)

OR03-2 Phase 1, Randomized, Controlled Trial of GFB-024, a Once-Monthly CB1 Inverse Agonist, in Healthy Overweight and Obese Participants and in Participants with Type 2 Diabetes Mellitus
por: Bilic, Sanela, et al.
Publicado: (2022)

OR03-6 Further Clinical Evaluation of Stem Cell-Derived Islet Replacement Therapy (VC-02) Demonstrates Production of C-Peptide with Improvements in Glycemic Control Parameters in Multiple Patients with Type 1 Diabetes and Hypoglycemia Unawareness
por: Bellin, Melena, et al.
Publicado: (2022)

THU313 Lactation As A Possible Protective Factor For Postpartum Diabetes In Women With Gestational Diabetes Mellitus: A Retrospective Analysis
por: Dávila-Parrilla, Verónica R, et al.
Publicado: (2023)

OR18-06 Metabolomic And Genetic Architecture Of Gestational Diabetes Subtypes
por: Lee, Kristen, et al.
Publicado: (2023)

OR18-04 Leptin Decreases Gluconeogenesis And Gluconeogenic Substrate Availability In Patients With Lipodystrophy
por: Quaye, Emmanuel, et al.
Publicado: (2023)

OR18-01 Massively Parallel Functional Assay Of Extracellular Insulin Receptor Variants
por: Aslanzadeh, Vahid, et al.
Publicado: (2023)

ODP251 Thioredoxin-Interacting Protein (Txnip) And Cellular Senescence: Potential Adverse Effects of Txnip Deficiency.
por: Abubaker, Mohammed, et al.
Publicado: (2022)

ODP167 Bell's Palsy As A Possible Post-Covid-19 Complication In Patient With Type 2 Diabetes
por: Kostitska, Iryna, et al.
Publicado: (2022)

RF04 | PSUN295 Evolution of Monomeric Multi-Agonists of GLP-1 and NPY Receptors
por: Chichura, Kylie, et al.
Publicado: (2022)

SAT057 Hyperglycemic Emergencies Following Vaccination Against COVID-19: A Descriptive Analysis Of Crude Adverse Event Data
por: Laskova, Anna, et al.
Publicado: (2023)

THU347 Diffusion Tensor Imaging Of The Tibial Nerve Can Detect Peripheral Neuropathy In Type 2 Diabetes
por: Park, Hyeong-Kyu, et al.
Publicado: (2023)

OR18-05 Interleukin 21 Drives The Development Of Autoimmune Diabetes Mellitus During Immune Checkpoint Inhibitor Cancer Therapy
por: Garcia Ortega, Jessica Rachel, et al.
Publicado: (2023)

OR18-02 Mammary Insulin Sensitivity Increases At The Onset Of Lactation And Promotes Metabolic Pathways Supporting Breast Milk Synthesis
por: Meng, Xin, et al.
Publicado: (2023)

OR26-03 Lower Serum Myostatin Levels Are Associated with Higher Insulin Sensitivity in Adults with Overweight/Obesity
por: Haines, Melanie S, et al.
Publicado: (2020)

ODP240 Routine Glucose-lowering Therapies and Risk of Adverse Outcomes in COVID-19 Patients with Diabetes: a Network Meta-analysis
por: Zhu, Zheng, et al.
Publicado: (2022)

PSUN340 Two cases of diffuse form of diazoxide-responsive congenital hyperinsulinism confirmed by 18F-DOPA PET-CT
por: Yu, Jeesuk, et al.
Publicado: (2022)

LBSUN289 Ketonuria — A Possible Early Indicator Of Impending Euglycemic DKA In Setting Of Recent SGLT-2 Inhibitor Use And Acute Stress
por: Arora, Gunjan, et al.
Publicado: (2022)

OR30-03 Racial Differences in Technology Use Among Type 1 Diabetes in a Safety-Net Hospital
por: Wirunsawanya, Kamonkiat, et al.
Publicado: (2020)

OR14-03 The Transcriptional Coactivation Function of EHMT2 Restricts Chronic Glucocorticoid Exposure Induced Insulin Resistance
por: Lee, Rebecca Arwyn, et al.
Publicado: (2020)

OR08-03 Association of Hemoglobin A1c with Early Postpartum Metabolic Syndrome in Women with Gestational Diabetes
por: Blair, Rachel A, et al.
Publicado: (2020)

SAT041 (18)F-FDG PET/CT Mapping Of Functional Microbial Niches To Understand Host Glucose Regulation After BCG Vaccinations
por: Dias, Hans, et al.
Publicado: (2023)

LBSUN290 A Rare, Sordid Tale Of The Two Most Dreaded Adverse Effects Of SGLT-2 Inhibitors Occurring Concurrently - Acute Pancreatitis And Euglycemic Diabetic Ketoacidosis - Within Days Of Initiating Empagliflozin Therapy.
por: Arora, Gunjan, et al.
Publicado: (2022)

THU251 Diagnostic Performance For Predicting Hepatic And Peripheral Tissue Insulin Resistance In Young Adult Men Using 1Hour Post Load Serum Glucose And Insulin Levels A Pilot Study
por: Julian Ledezma, Andrés, et al.
Publicado: (2023)

SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
por: Oprea, Mihaela, et al.
Publicado: (2019)

THU272 Early Time Restricted Feeding As a Weight Neutral Approach To Improved Glycemic Variation
por: Nasserifar, Shabnam, et al.
Publicado: (2023)

FRI605 Inhibition Of Intestinal SGLT1 With Mizagliflozin For The Treatment Of Post-bariatric Hypoglycemia
por: Margaret Lawler, Helen, et al.
Publicado: (2023)

SAT084 Maternally Inherited Diabetes With Deafness: A Rare And Challenging Diagnosis Of Diabetes
por: Cuan, Katherine, et al.
Publicado: (2023)

THU006 Exploring Primary Care Resident Perspectives On Diabetes Education In Training
por: Francis, Nnenia, et al.
Publicado: (2023)

THU366 Type 1 Diabetes Complicated By Multiple Episodes Of Diabetic Ketoacidosis Secondary To Flares Of Hidradenitis Suppurativa
por: Vasavada, Sheel R, et al.
Publicado: (2023)

THU391 A Case Of Unrecognized Hypoglycemia Due To Methadone Use In A Non-Diabetes Patient
por: Owais, Darakhshan, et al.
Publicado: (2023)

SAT044 Cornus officinalis Decreases Incidence Of Type 1 Diabetes Onset And Hyperglycemia In The Non-obese Diabetic Mouse
por: Fletcher, Justin D, et al.
Publicado: (2023)

LBODP058 Evaluation Of Factors Associated With The Development Of Diabetic Retinopathy Based On A Case-control Study
por: Nathani, Pratiksha Shankarlal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mnvgb8ja3k3qmbh0ii72297bak